CDC Allocates $1.6M for Controversial Hepatitis B Vaccine Study
Audio narration · Coming soon
The CDC has reportedly allocated $1.6 million to fund a study investigating alleged harms of the hepatitis B vaccine. This decision has sparked growing outrage due to concerns about the ethics of the trial. The announcement marks a significant development in vaccine research and public health discourse.
Why this matters
PRISM scored this story 60/100 for interest.
Originally published by arstechnica